Request for TOC Request for Sample
BUY NOW

Global Varicose Vein Treatment Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Healthcare | Upcoming Report | Dec 2024 | Global | 350 Pages | No of Tables: 60 | No of Figures: 220
Nucleus

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Varicose Vein Treatment Market

Market Size in USD Billion

CAGR :  %

USD 818.61 Million USD 1,404.42 Million 2024 2032
Forecast Period
2025 –2032
Market Size(Base Year)
USD 818.61 Million
Market Size (Forecast Year)
USD 1,404.42 Million
CAGR
%
Major Markets Players
  • Medtronic
  • AngioDynamics
  • biolitec AG
  • CANDELA CORPORATION
  • Lumenis

Global Varicose Vein Treatment Market Segmentation, By Treatment Mode (Endovenous Ablation, Injection Sclerotherapy, and Surgical Ligation/Stripping), Product (Ablation Devices, Venous Closure Products, and Surgical Products), End-User (Hospitals, Specialized Clinics, Ambulatory Surgical Centres, and Others) – Industry Trends and Forecast to 2032

Varicose Vein Treatment Market

 

Varicose Vein Treatment Market Analysis

The varicose vein treatment market has been experiencing significant growth due to increasing cases of varicose veins, driven by factors such as aging populations and rising obesity rates. This condition, which causes swollen, twisted veins, particularly in the legs, can lead to discomfort and, if untreated, serious complications. Treatments include sclerotherapy, laser therapies, radiofrequency ablation sysytem, and surgical options. Recent developments in non-invasive procedures, such as endovenous laser therapy (EVLT) and foam sclerotherapy, have revolutionized the market, providing patients with effective and minimally painful solutions. The market is also witnessing advancements in treatment devices, with companies introducing cutting-edge technologies. In addition, increased awareness, growing healthcare infrastructure, and the rising focus on aesthetic concerns are fueling market expansion. With an aging global population and growing demand for effective treatments, the varicose vein treatment market is expected to continue its upward trajectory in the coming years.

Varicose Vein Treatment Market Size

The global varicose vein treatment market size was valued at USD 818.61 million in 2024 and is projected to reach USD 1404.42 million by 2032, with a CAGR of 6.98% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Varicose Vein Treatment Market Trends

Innovations in Endovenous Laser Therapy”

The varicose vein treatment market is experiencing steady growth, driven by advancements in non-invasive therapies and an increasing prevalence of the condition, particularly in aging populations. Recent innovations, such as endovenous laser therapy (EVLT) and radiofrequency ablation (RFA), offer patients minimally invasive and effective solutions for varicose veins. A key trend in the market is the growing preference for minimally invasive procedures, which provide quicker recovery times and fewer complications compared to traditional surgical options. With the increasing awareness about varicose vein treatments and enhanced patient comfort, the market is seeing expanding demand across both developed and emerging regions. These trends are expected to drive continued innovation and market growth in the coming years.

Report Scope and Varicose Vein Treatment Market Segmentation    

Attributes

Varicose Vein Treatment  Key Market Insights

Segments Covered

  • By Treatment Mode: Endovenous Ablation, Injection Sclerotherapy, and Surgical Ligation/Stripping
  • By Product: Ablation Devices, Venous Closure Products, and Surgical Products
  • By End-User: Hospitals, Specialized Clinics, Ambulatory Surgical Centres, and Others

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Key Market Players

Medtronic (U.S.), AngioDynamics (U.S.), biolitec® Holding GmbH & Co KG (Germany), Lumenis Be Ltd. (Israel), Dornier MedTech (Germany), Energist Ltd. (U.K.), Eufoton s.r.l. (Italy), Teleflex Incorporated (U.S.), Quanta System (Italy), Sciton (U.S.), Fotona (Slovenia), BTG (U.K.), Merz Pharma (Germany), Alma Lasers (Israel), The Vein Company (U.S.), Grocare Herbals LLP (India), Chemical Factory Kreussler & Co. GmbH (Germany), LeMaitre Vascular, Inc. (U.S.), VVT Medical (U.K.)

Market Opportunities

  • Technological Advancements in Treatment Methods
  • Integration of Artificial Intelligence and Robotics

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Varicose Vein Treatment Market Definition

Varicose vein treatment refers to medical procedures used to manage or eliminate varicose veins, which are swollen, twisted veins typically found in the legs. These treatments aim to alleviate symptoms such as pain and discomfort, and prevent complications such as blood clots or ulcers. Options include non-invasive methods such as sclerotherapy, where a solution is injected into veins to cause them to collapse, and laser therapies such as endovenous laser therapy (EVLT) and radiofrequency ablation (RFA), which use heat to seal off affected veins. Surgical treatments are also available, including vein stripping, to remove or tie off problematic veins.

Varicose Vein Treatment Market Dynamics

Drivers

  • Rising Prevalence of Varicose Veins

Varicose veins are increasingly prevalent, especially among the aging population. As people age, the elasticity of vein walls decreases, and the one-way valves in veins weaken, leading to blood pooling and the formation of varicose veins. This condition affects a significant portion of the population, particularly individuals over 50, with women being more susceptible. With the global population rapidly aging, the incidence of varicose veins is expected to rise, making it a major health concern. As a result, there is a growing demand for effective treatment options, making the aging population a key driver for the varicose vein treatment market.

  • Rising Disposable Incomes in Emerging Markets

In emerging markets such as India, China, and Brazil, rising disposable incomes are significantly improving access to healthcare services, including advanced medical treatments such as varicose vein procedures. As the middle class expands and more people can afford private healthcare options, there is a growing demand for minimally invasive treatments for varicose veins. In addition, the increasing awareness of aesthetic concerns and health risks associated with untreated varicose veins is driving more individuals to seek professional care. This trend is particularly noticeable in urban areas, where healthcare infrastructure is improving, contributing to the expansion of the varicose vein treatment market in these regions.

Opportunities

  • Technological Advancements in Treatment Methods

Continuous advancements in medical technology have significantly transformed varicose vein treatments. Innovative techniques such as laser therapies, radiofrequency ablation (RFA), and endovenous laser treatment (EVLT) provide less invasive and more effective alternatives to traditional surgical methods. These technologies offer patients shorter recovery times, minimal scarring, and reduced risks compared to older procedures. As a result, there is a growing demand for these non-invasive treatments, creating a significant market opportunity. Companies that invest in the development of cutting-edge devices and techniques can attract a broader customer base, especially those seeking quick, safe, and minimally disruptive solutions for varicose veins.

  • Integration of Artificial Intelligence and Robotics

The integration of artificial intelligence (AI) and robotic-assisted surgeries into varicose vein treatment procedures is revolutionizing the field by enhancing precision and improving treatment outcomes. AI algorithms can aid in accurate diagnosis, treatment planning, and monitoring, while robotic systems ensure minimal invasiveness and increased surgical accuracy. These advancements can reduce complications, shorten recovery times, and improve patient satisfaction. By streamlining operations and reducing human error, AI and robotics also help lower treatment costs. This creates a significant market opportunity, as both healthcare providers and patients are increasingly attracted to more efficient, cost-effective, and successful treatment options for varicose veins.

Restraints/Challenges

  • Competition from Alternative Treatments

Alternative therapies, such as herbal treatments and compression stockings, are commonly used by individuals seeking less invasive, lower-cost solutions for varicose veins. These options, while generally safer and more affordable, may not offer the same level of effectiveness as medical treatments such as laser therapy or radiofrequency ablation (RFA). However, in regions where healthcare costs are a significant concern, these alternative therapies are often preferred due to their lower price point and ease of access. This presents a challenge to the varicose vein treatment market, as it competes with these non-medical alternatives, particularly in price-sensitive markets.

  •  High Treatment Costs

Minimally invasive procedures such as laser therapy and radiofrequency ablation (RFA) offer effective treatments for varicose veins, but their high upfront costs pose a significant barrier for many patients. These advanced treatments are often not covered by insurance, especially in regions with limited healthcare coverage or where insurance policies categorize them as elective or cosmetic procedures. This financial burden can deter individuals from seeking treatment, particularly in developing regions where affordability is a major concern. As a result, many patients opt for less expensive, non-medical alternatives, thus limiting the growth of the varicose vein treatment market in these areas.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Varicose Vein Treatment Market Scope

The market is segmented on the basis of treatment mode, product, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment Mod

  • Endovenous Ablation
  • Injection Sclerotherapy
  • Surgical Ligation/Stripping

Product

  • Ablation Devices
  • Venous Closure Products
  • Surgical Products

End-User

  • Hospitals
  • Specialized Clinics
  • Ambulatory Surgical Centres
  • Others

Varicose Vein Treatment Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, treatment mode, product, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the varicose vein treatment market, driven by a rising incidence of varicose veins, higher disposable incomes, and access to advanced healthcare infrastructure. The region also faces an increasing prevalence of related health disorders, compounded by a growing trend toward unhealthy lifestyles. These factors contribute to the strong demand for varicose vein treatments in North America.

The Asia-Pacific region is expected to see significant growth in the varicose vein treatment market, driven by improvements in healthcare infrastructure and increased patient awareness. Rising disposable incomes are enabling more individuals to access treatment, while growing recognition of the benefits of early intervention is fueling demand. These factors combined are positioning the region for strong market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Varicose Vein Treatment Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Varicose Vein Treatment Market Leaders Operating in the Market Are:

  • Medtronic (U.S.)
  • AngioDynamics (U.S.)
  • biolitec® Holding GmbH & Co KG (Germany)
  • Lumenis Be Ltd. (Israel)
  • Dornier MedTech (Germany)
  • Energist Ltd. (U.K.)
  • Eufoton s.r.l. (Italy)
  • Teleflex Incorporated (U.S.)
  • Quanta System (Italy)
  • Sciton (U.S.)
  • Fotona (Slovenia)
  • BTG (U.K.)
  • Merz Pharma (Germany)
  • Alma Lasers (Israel)
  • The Vein Company (U.S.)
  • India Grocare Herbals LLP (India)
  • Chemical Factory Kreussler & Co. GmbH (Germany)
  • LeMaitre Vascular, Inc. (U.S.)
  • VVT Medical (U.K.)

Latest Developments in Varicose Vein Treatment Market

  • In June 2024, doctors began utilizing the new Duo stent developed by Koninklijke Philips N.V., following its approval by the FDA. This stent is designed to assist patients with chronic vein issues (CVI) that result in blood flow blockages. The Duo stent offers an advanced solution for improving circulation in patients suffering from these conditions
  • In January 2024, VVT Med Ltd. (VVT Medical) entered into a strategic distribution partnership with Methapharm Inc. to distribute its ScleroSafe platform for treating varicose veins in the U.S. This collaboration aims to expand the reach of the innovative ScleroSafe technology, enhancing treatment options for varicose vein patients. The partnership marks a significant step in bringing advanced varicose vein treatment solutions to the U.S. market
  • In June 2023, Theraclion received approval from the U.S. FDA to launch a pivotal clinical study assessing the effectiveness of Sonovein for treating primary insufficiency of the great saphenous veins. This study aims to further evaluate the potential of Sonovein as a non-invasive treatment for venous insufficiency. The FDA approval marks a significant step forward in advancing the clinical application of Sonovein in the U.S. market
  • In April 2022, I-VASC, an Italy-based medical device company, secured EUR 1.8 million in Series A funding to advance its VELEX device. The VELEX device is designed for the treatment of varicose veins, offering an innovative solution in the field. This investment aims to support the development and market expansion of the device, enhancing treatment options for varicose vein patients


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Testimonial
Claudio Rondena Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future